1. Home
  2. DRMA vs MYSZ Comparison

DRMA vs MYSZ Comparison

Compare DRMA & MYSZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • MYSZ
  • Stock Information
  • Founded
  • DRMA 2014
  • MYSZ 1999
  • Country
  • DRMA United States
  • MYSZ Israel
  • Employees
  • DRMA N/A
  • MYSZ N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • MYSZ Computer Software: Prepackaged Software
  • Sector
  • DRMA Health Care
  • MYSZ Technology
  • Exchange
  • DRMA Nasdaq
  • MYSZ Nasdaq
  • Market Cap
  • DRMA 1.7M
  • MYSZ 2.0M
  • IPO Year
  • DRMA 2021
  • MYSZ N/A
  • Fundamental
  • Price
  • DRMA $1.12
  • MYSZ $1.54
  • Analyst Decision
  • DRMA Strong Buy
  • MYSZ Strong Buy
  • Analyst Count
  • DRMA 1
  • MYSZ 1
  • Target Price
  • DRMA $6.00
  • MYSZ $5.00
  • AVG Volume (30 Days)
  • DRMA 85.2K
  • MYSZ 33.9K
  • Earning Date
  • DRMA 11-13-2024
  • MYSZ 11-26-2024
  • Dividend Yield
  • DRMA N/A
  • MYSZ N/A
  • EPS Growth
  • DRMA N/A
  • MYSZ N/A
  • EPS
  • DRMA N/A
  • MYSZ N/A
  • Revenue
  • DRMA N/A
  • MYSZ $9,632,000.00
  • Revenue This Year
  • DRMA N/A
  • MYSZ $45.80
  • Revenue Next Year
  • DRMA N/A
  • MYSZ N/A
  • P/E Ratio
  • DRMA N/A
  • MYSZ N/A
  • Revenue Growth
  • DRMA N/A
  • MYSZ 43.89
  • 52 Week Low
  • DRMA $1.11
  • MYSZ $1.40
  • 52 Week High
  • DRMA $13.35
  • MYSZ $7.12
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 34.78
  • MYSZ 46.46
  • Support Level
  • DRMA $1.22
  • MYSZ $1.47
  • Resistance Level
  • DRMA $1.54
  • MYSZ $1.64
  • Average True Range (ATR)
  • DRMA 0.12
  • MYSZ 0.15
  • MACD
  • DRMA -0.01
  • MYSZ 0.01
  • Stochastic Oscillator
  • DRMA 2.35
  • MYSZ 22.22

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

About MYSZ My Size Inc.

My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.

Share on Social Networks: